Related Experiment Video
Updated: Mar 12, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
Paola Faverio1, Anna Stainer2, Giulia Bonaiti3
1Dipartimento Cardio-Toraco-Vascolare, University of Milan Bicocca, Respiratory Unit, San Gerardo Hospital, ASST di Monza, Via Pergolesi 33, 20900 Monza, Italy. paola.faverio@gmail.com.
Non-tuberculous mycobacteria (NTM) lung disease is common in bronchiectasis patients. While NTM infection presents unique characteristics and treatment responses, further research is needed for optimal management.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Chronic airway infection is central to bronchiectasis pathogenesis.
- Non-tuberculous mycobacteria (NTM) infections are gaining attention in bronchiectasis.
- Pulmonary NTM (pNTM) disease requires detailed characterization in this patient population.
Purpose of the Study:
- To describe clinical features, diagnosis, treatment, and outcomes of bronchiectasis patients with pNTM disease.
- To compare pNTM disease with chronic Pseudomonas aeruginosa infection and other bacterial infections.
- To identify potential indicators for suspecting NTM infection in bronchiectasis.
Main Methods:
- Prospective, observational study of 261 adult bronchiectasis patients (2012-2015).
- Patients categorized into three groups: pNTM disease, chronic P. aeruginosa infection, or other chronic bacterial infection.
- Clinical, radiological, and microbiological data were collected and analyzed.
Main Results:
- NTM were isolated in 12% of patients; 23 (8.8%) were diagnosed with pNTM disease.
- pNTM patients exhibited cylindrical bronchiectasis, 'tree-in-bud' pattern, weight loss, lower disease severity, and fewer exacerbations compared to P. aeruginosa.
- Treatment yielded radiological improvement in 68% and culture conversion in 37% of pNTM patients; recurrence was observed in 21%.
Conclusions:
- NTM isolation is frequent in bronchiectasis, with distinct clinical and radiological features.
- Predictive parameters for NTM infection in bronchiectasis are limited.
- Treatment strategies and monitoring for pNTM disease in bronchiectasis warrant further investigation.
More Related Videos
10:38Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Published on: September 9, 2015
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Bacterial Phylum Actinobacteria